Showing results (211-220 of 810) with videos related to
Sort By:
Pageof 81
Journal of Hepatology|December 3, 2014
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasisMartina Sombetzki, Claudia D Fuchs, Peter Fickert, et al.Zeitschrift Fur Gastroenterologie|November 19, 2019
Chronic gastric ulcer disease complicating selective internal radiation therapy (SIRT) in a patient with cholangiocellular carcinomaAndreas Blesl, Iva Brcic, Werner Jaschke, et al.Gut|February 26, 2021
From the origin of NASH to the future of metabolic fatty liver diseaseAndreas Geier, Dina Tiniakos, Helmut Denk, et al.Hepatology (Baltimore, Md.)|June 20, 2019
Liver Injury and Failure in Critical IllnessThomas Horvatits, Andreas Drolz, Michael Trauner, et al.Seminars in Liver Disease|February 13, 2016
Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver DiseaseClaudia D Fuchs, Stefan A Traussnigg, Michael TraunerLiver International : Official Journal of the International Association for the Study of the Liver|July 30, 2021
Diet and exercise in NAFLD/NASH: Beyond the obviousGeorg Semmler, Christian Datz, Thomas Reiberger, et al.Journal of Hepatology|April 29, 2015
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyondUlrich Beuers, Michael Trauner, Peter Jansen, et al.Best Practice & Research. Clinical Gastroenterology|April 19, 2011
Fibrosis in autoimmune and cholestatic liver diseaseMelitta Penz-Österreicher, Christoph H Österreicher, Michael TraunerBiochimica Et Biophysica Acta|January 4, 2011
Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone diseaseThierry Claudel, Gernot Zollner, Martin Wagner, et al.World Journal of Gastroenterology|October 30, 2019
Gut-liver axis signaling in portal hypertensionBenedikt Simbrunner, Mattias Mandorfer, Michael Trauner, et al.Pageof 81